Beijing Succeeder Technology

Beijing Succeeder Technology Interest Coverage

The Interest Coverage Ratio of Beijing Succeeder Technology (688338.SS) as of Oct 27, 2026 is 4.78. In the previous year, Interest Coverage Ratio was 4.37 — a change of 9.59% (higher).

Interest Coverage

4.78

YoY

9.59%

Last updated:

Interest Coverage Ratio of Beijing Succeeder Technology is 2024 4.78 . Interest Coverage Ratio of Beijing Succeeder Technology was 2023 4.37 . It decreases by 9.59% higher compared to the previous year.

The Beijing Succeeder Technology Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
31.17 CNY
Jan 1, 2019
17.39 CNY
Jan 1, 2020
10.47 CNY
Jan 1, 2021
4.07 CNY
Jan 1, 2022
3.36 CNY
Jan 1, 2023
4.37 CNY
Jan 1, 2024
4.78 CNY
The Beijing Succeeder Technology Interest Coverage history
YEARInterest CoverageYoY
4.78+9.59%
4.37+30.09%
3.36-17.56%
4.07-61.12%
10.47-39.78%
17.39-44.21%
31.17—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Beijing Succeeder Technology Stock analysis

What does Beijing Succeeder Technology do? Beijing Succeeder Technology Inc generates revenue through the research, development, production, and sales of detection instruments, reagents, and consumables for thrombosis and hemostasis in the in-vitro diagnosis field. The company provides medical institutions with automated detection equipment for blood coagulation, blood rheology, hematocrit, and platelet aggregation, along with supporting reagents and consumables. Its product portfolio includes automatic coagulation testers, coagulation quality control kits, Newtonian fluid quality controls, reaction cups, and SAW blood rheology special cleaning. The firm serves domestic and overseas markets with these offerings. The company's primary customers are medical institutions that require automated detection systems for blood-related diagnostics. Products like automatic coagulation testers and coagulation quality control kits are sold to these institutions for use in clinical settings. Reagents and consumables such as Newtonian fluid quality controls and reaction cups form recurring revenue streams through regular purchases. SAW blood rheology special cleaning is also part of the consumable product line sold to the same customer segment. Beijing Succeeder Technology Inc focuses on the in-vitro diagnosis sector, specifically targeting thrombosis and hemostasis detection. The firm's products are designed to meet the needs of medical institutions for accurate and efficient blood-related diagnostic testing. By offering a comprehensive range of instruments, reagents, and consumables, the company ensures ongoing customer engagement and repeat business through essential daily supplies. Beijing Succeeder Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Beijing Succeeder Technology stock

Interest Coverage Ratio of Beijing Succeeder Technology is 4.78 in 2024.

Interest Coverage Ratio of Beijing Succeeder Technology changed from 4.37 to 4.78, representing a 9.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Beijing Succeeder Technology since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Beijing Succeeder Technology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Beijing Succeeder Technology

All Key Metrics — Beijing Succeeder Technology